Trelleborg is known for supplying original equipment manufacturers and pharmaceutical companies with high-quality tubing and hose products, such as its PharmaTube platinum silicone tubing for single- and multi-use pharmaceutical applications. The company’s portfolio also includes a broad range of O-Rings, seals, bearings, and composite products.
Last year the company expanded its milling and extrusion capabilities at the site, and now the three-phase expansion project at Northborough will bring capacities and capabilities online incrementally over the next 24 to 36 months, with Phase 1 commencing in January 2023. The expansion is expected to create at least 50 new jobs.
Linda Muroski, President of Trelleborg Healthcare & Medical, said: “The site will expand our manufacturing capacities of Class 7 and 8 cleanrooms by 25,000 ft2 to meet the market’s growing demand for biopharmaceutical applications, such as silicone tubing and hose, assemblies, and other integrated solutions.
“The investment is a key milestone in our global biopharmaceutical strategy and will enable us to expand our offerings to existing and new customers in the industry. Our customers need a global partner for growth, and we are committed to being that partner.”
Florance Veronelli, Global Business Development Lead for Biopharmaceutical, added: “The expansion will enable us to increase our manufacturing capacities for extrusion and molding and offer enhanced flexible manufacturing solutions. As a full-service provider to the biopharmaceutical industry, our value-added offering will include assembly, kitting, contract manufacturing, packaging, validation, supply chain management, and more.”